Results 201 to 210 of about 982,573 (275)

Co-Targeting BCL-xL with MCL-1 Induces Lethal Mitochondrial Dysfunction in Diffuse Mesothelioma. [PDF]

Mol Cancer Ther
Xu Y, Medina CG, Surman DR, Dobrolecki LE, Vilchis M, Ramineni M, Hilsenbeck SG, Li Y, Li Y, Li N, Wu S, Aggison JC, Chen X, Zhu Y, Shen YH, Ripley RT.   +15 more
europepmc   +1 more source

Therapeutic applications of mesenchymal stem cell-derived extracellular vesicles in pain management: A narrative review of emerging evidence and future directions. [PDF]

World J Stem Cells
Khan SA, Gangadaran P, Tiwari P, Rajendran RL, Jamal A, Hattiwale SH, Anand K, Jha SK, Hong CM, Ahn BC, Parvez S.   +10 more
europepmc   +1 more source

Native and Freeze-Dried Bacterial Nanocellulose as Fat Replacers in Low-Fat Meat Emulsions: A Comparative Study of Techno-Functional Performance. [PDF]

Foods
Balquinta ML, Nagai NF, Golzi ME, Pino Ibañez NA, Marchetti L, Andrés SC, Lorenzo G, Domínguez-Valencia R.   +7 more
europepmc   +1 more source

GLP-1 Receptor Agonists at the Crossroads of Circadian Biology, Sleep, and Metabolic Disease. [PDF]

Int J Mol Sci
Gandhi A, Phyu EM, Koom-Dadzie K, Dickson KB, Halm J.   +4 more
europepmc   +1 more source

Why you should not skip tailored exercise interventions when using incretin mimetics for weight loss. [PDF]

Front Endocrinol (Lausanne)
Gross K, Brinkmann C.
europepmc   +1 more source

The promise of incretin-based pharmacotherapies for metabolic dysfunction-associated fatty liver disease. [PDF]

Hepatol Int
Elangovan H, Gunton JE, Zheng MH, Fan JG, Goh GBB, Gronbaek H, George J.   +6 more
europepmc   +1 more source